232 related articles for article (PubMed ID: 37731815)
1. MYC-an emerging player in mitochondrial diseases.
Purhonen J; Klefström J; Kallijärvi J
Front Cell Dev Biol; 2023; 11():1257651. PubMed ID: 37731815
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial complex III deficiency drives c-MYC overexpression and illicit cell cycle entry leading to senescence and segmental progeria.
Purhonen J; Banerjee R; Wanne V; Sipari N; Mörgelin M; Fellman V; Kallijärvi J
Nat Commun; 2023 Apr; 14(1):2356. PubMed ID: 37095097
[TBL] [Abstract][Full Text] [Related]
3. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
[TBL] [Abstract][Full Text] [Related]
4. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.
Maya-Mendoza A; Ostrakova J; Kosar M; Hall A; Duskova P; Mistrik M; Merchut-Maya JM; Hodny Z; Bartkova J; Christensen C; Bartek J
Mol Oncol; 2015 Mar; 9(3):601-16. PubMed ID: 25435281
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
6. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells.
Liu Q; Sun Y; Fei Z; Yang Z; Duan K; Zi J; Cui Q; Yu M; Xiong W
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):707-714. PubMed ID: 31187140
[TBL] [Abstract][Full Text] [Related]
7. Alterations in c-Myc phenotypes resulting from dynamin-related protein 1 (Drp1)-mediated mitochondrial fission.
Sarin M; Wang Y; Zhang F; Rothermund K; Zhang Y; Lu J; Sims-Lucas S; Beer-Stolz D; Van Houten BE; Vockley J; Goetzman ES; Graves JA; Prochownik EV
Cell Death Dis; 2013 Jun; 4(6):e670. PubMed ID: 23764851
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
Fosslien E
Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
[TBL] [Abstract][Full Text] [Related]
10. Nonhormonal therapy for endometriosis based on energy metabolism regulation.
Kobayashi H; Shigetomi H; Imanaka S
Reprod Fertil; 2021 Dec; 2(4):C42-C57. PubMed ID: 35118411
[TBL] [Abstract][Full Text] [Related]
11. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells.
La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L
Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389
[No Abstract] [Full Text] [Related]
12. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus.
Delavallée L; Mathiah N; Cabon L; Mazeraud A; Brunelle-Navas MN; Lerner LK; Tannoury M; Prola A; Moreno-Loshuertos R; Baritaud M; Vela L; Garbin K; Garnier D; Lemaire C; Langa-Vives F; Cohen-Salmon M; Fernández-Silva P; Chrétien F; Migeotte I; Susin SA
Mol Metab; 2020 Oct; 40():101027. PubMed ID: 32480041
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.
Wang H; Lu J; Kulkarni S; Zhang W; Gorka JE; Mandel JA; Goetzman ES; Prochownik EV
J Biol Chem; 2019 Apr; 294(14):5466-5486. PubMed ID: 30755479
[TBL] [Abstract][Full Text] [Related]
15. c-Myc and AMPK Control Cellular Energy Levels by Cooperatively Regulating Mitochondrial Structure and Function.
Edmunds LR; Sharma L; Wang H; Kang A; d'Souza S; Lu J; McLaughlin M; Dolezal JM; Gao X; Weintraub ST; Ding Y; Zeng X; Yates N; Prochownik EV
PLoS One; 2015; 10(7):e0134049. PubMed ID: 26230505
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Duarte FV; Palmeira CM; Rolo AP
Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial structure, function and dynamics are temporally controlled by c-Myc.
Graves JA; Wang Y; Sims-Lucas S; Cherok E; Rothermund K; Branca MF; Elster J; Beer-Stolz D; Van Houten B; Vockley J; Prochownik EV
PLoS One; 2012; 7(5):e37699. PubMed ID: 22629444
[TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma.
Donati G; Ravà M; Filipuzzi M; Nicoli P; Cassina L; Verrecchia A; Doni M; Rodighiero S; Parodi F; Boletta A; Vellano CP; Marszalek JR; Draetta GF; Amati B
Mol Oncol; 2022 Mar; 16(5):1132-1152. PubMed ID: 34632715
[TBL] [Abstract][Full Text] [Related]
19. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
